BRKR
Bruker CorporationNASDAQHealthcare$36.76+1.88%ClosedMarket Cap: $5.60B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.27
P/S
1.63
EV/EBITDA
24.70
DCF Value
$53.55
FCF Yield
0.8%
Div Yield
0.5%
Margins & Returns
Gross Margin
46.6%
Operating Margin
5.4%
Net Margin
-0.3%
ROE
-0.4%
ROA
-0.2%
ROIC
-1.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $977.2M | 47.8% | $76.3M | $26.0M | $0.10 | $0.05 |
| FY 2025 | $3.44B | 45.6% | $216.6M | $-8.6M | $-0.15 | $0.20 |
| Q3 2025 | $860.5M | 44.9% | $66.9M | $-59.6M | $-0.41 | $0.05 |
| Q2 2025 | $797.4M | 44.9% | $11.9M | $7.6M | $0.05 | $0.05 |
| Q1 2025 | $801.4M | 48.8% | $31.8M | $17.4M | $0.11 | $0.05 |
| Q4 2024 | $979.6M | 50.4% | $72.1M | $13.7M | $0.09 | $0.05 |
| FY 2024 | $3.37B | 49.0% | $253.1M | $113.1M | $0.76 | $0.20 |
| Q3 2024 | $864.4M | 48.4% | $68.1M | $40.9M | $0.27 | $0.05 |
| Q2 2024 | $800.7M | 48.0% | $48.1M | $7.6M | $0.05 | $0.05 |
| Q1 2024 | $721.7M | 48.9% | $64.8M | $50.9M | $0.35 | $0.05 |
| Q4 2023 | $854.5M | 50.4% | $103.5M | $205.5M | $1.41 | $0.05 |
| FY 2023 | $2.96B | 51.0% | $436.9M | $427.2M | $2.90 | $0.20 |